Inicio › SHIELD THERAPEUTICS ORD 1.5P › Noticias › Executive interview – Shield Therapeutics SHIELD THERAPEUTICS ORD 1.5P FichaCotizacionesGráficoSeñalesNoticiasAnálisisWarrantsGeneralMuro - GBX (-) - Diferidos de 15 min - London Stock Exchange Apertura: - Cambio neto: - Volumen: - Mínimo: - Máximo: - Distancia Mín/Máx: - Tipo: Acciones Ticker: STX ISIN: GB00BYV81293 Ficha Cotizaciones Gráfico Señales Noticias Análisis Warrants General Muro Executive interview – Shield Therapeutics 0 97 Shield Therapeutics is a commercial-stage speciality pharmaceutical company based in the United Kingdom that listed on AIM in 2016. Its primary focus is the ... Edison